nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—XDH—Cisplatin—germ cell cancer	0.145	0.277	CbGbCtD
Carvedilol—PTGS1—Ifosfamide—germ cell cancer	0.0871	0.166	CbGbCtD
Carvedilol—PTGS1—Etoposide—germ cell cancer	0.0416	0.0793	CbGbCtD
Carvedilol—CYP2C9—Ifosfamide—germ cell cancer	0.0351	0.0667	CbGbCtD
Carvedilol—CYP2E1—Etoposide—germ cell cancer	0.0322	0.0612	CbGbCtD
Carvedilol—ABCB1—Dactinomycin—germ cell cancer	0.0288	0.0549	CbGbCtD
Carvedilol—CYP3A4—Ifosfamide—germ cell cancer	0.0204	0.0388	CbGbCtD
Carvedilol—CYP1A2—Etoposide—germ cell cancer	0.0186	0.0354	CbGbCtD
Carvedilol—ABCB1—Vinblastine—germ cell cancer	0.018	0.0344	CbGbCtD
Carvedilol—CYP2C9—Cisplatin—germ cell cancer	0.0171	0.0325	CbGbCtD
Carvedilol—CYP2D6—Vinblastine—germ cell cancer	0.017	0.0324	CbGbCtD
Carvedilol—ABCB1—Cisplatin—germ cell cancer	0.0165	0.0315	CbGbCtD
Carvedilol—ABCB1—Etoposide—germ cell cancer	0.0163	0.031	CbGbCtD
Carvedilol—CYP3A4—Vinblastine—germ cell cancer	0.0108	0.0206	CbGbCtD
Carvedilol—ABCB1—Methotrexate—germ cell cancer	0.0107	0.0205	CbGbCtD
Carvedilol—CYP3A4—Etoposide—germ cell cancer	0.00974	0.0185	CbGbCtD
Carvedilol—GJA1—Vinorelbine—Vinblastine—germ cell cancer	0.00435	1	CbGdCrCtD
Carvedilol—VCAM1—trigeminal ganglion—germ cell cancer	0.00161	0.00777	CbGeAlD
Carvedilol—HIF1A—trigeminal ganglion—germ cell cancer	0.00154	0.00747	CbGeAlD
Carvedilol—NDUFC2—neck—germ cell cancer	0.00151	0.00731	CbGeAlD
Carvedilol—GJA1—trigeminal ganglion—germ cell cancer	0.0015	0.00725	CbGeAlD
Carvedilol—HIF1A—embryo—germ cell cancer	0.00149	0.00721	CbGeAlD
Carvedilol—GJA1—embryo—germ cell cancer	0.00145	0.007	CbGeAlD
Carvedilol—VCAM1—eye—germ cell cancer	0.00138	0.00669	CbGeAlD
Carvedilol—VCAM1—retina—germ cell cancer	0.00137	0.00663	CbGeAlD
Carvedilol—HIF1A—brainstem—germ cell cancer	0.00137	0.00661	CbGeAlD
Carvedilol—HIF1A—eye—germ cell cancer	0.00133	0.00644	CbGeAlD
Carvedilol—GJA1—brainstem—germ cell cancer	0.00133	0.00641	CbGeAlD
Carvedilol—HIF1A—retina—germ cell cancer	0.00132	0.00638	CbGeAlD
Carvedilol—SELE—skin of body—germ cell cancer	0.00131	0.00633	CbGeAlD
Carvedilol—NDUFC2—trigeminal ganglion—germ cell cancer	0.0013	0.00631	CbGeAlD
Carvedilol—GJA1—eye—germ cell cancer	0.00129	0.00624	CbGeAlD
Carvedilol—NPPB—endocrine gland—germ cell cancer	0.00128	0.00619	CbGeAlD
Carvedilol—GJA1—retina—germ cell cancer	0.00128	0.00619	CbGeAlD
Carvedilol—NPPB—head—germ cell cancer	0.00126	0.00611	CbGeAlD
Carvedilol—HIF1A—telencephalon—germ cell cancer	0.00121	0.00587	CbGeAlD
Carvedilol—VCAM1—decidua—germ cell cancer	0.0012	0.00578	CbGeAlD
Carvedilol—VEGFA—trigeminal ganglion—germ cell cancer	0.00118	0.00572	CbGeAlD
Carvedilol—GJA1—telencephalon—germ cell cancer	0.00118	0.00569	CbGeAlD
Carvedilol—HIF1A—skin of body—germ cell cancer	0.00116	0.0056	CbGeAlD
Carvedilol—HIF1A—decidua—germ cell cancer	0.00115	0.00556	CbGeAlD
Carvedilol—SELE—uterus—germ cell cancer	0.00114	0.0055	CbGeAlD
Carvedilol—NDUFC2—eye—germ cell cancer	0.00112	0.00543	CbGeAlD
Carvedilol—GJA1—skin of body—germ cell cancer	0.00112	0.00543	CbGeAlD
Carvedilol—SELE—pituitary gland—germ cell cancer	0.00112	0.0054	CbGeAlD
Carvedilol—GJA1—decidua—germ cell cancer	0.00112	0.0054	CbGeAlD
Carvedilol—NDUFC2—retina—germ cell cancer	0.00111	0.00539	CbGeAlD
Carvedilol—CYP1A2—urine—germ cell cancer	0.0011	0.0053	CbGeAlD
Carvedilol—SELE—medulla oblongata—germ cell cancer	0.00108	0.00521	CbGeAlD
Carvedilol—VCAM1—uterus—germ cell cancer	0.00105	0.00506	CbGeAlD
Carvedilol—CYP2C9—urine—germ cell cancer	0.00104	0.00504	CbGeAlD
Carvedilol—VCAM1—pituitary gland—germ cell cancer	0.00103	0.00497	CbGeAlD
Carvedilol—NDUFC2—telencephalon—germ cell cancer	0.00102	0.00495	CbGeAlD
Carvedilol—HIF1A—gonad—germ cell cancer	0.00101	0.0049	CbGeAlD
Carvedilol—HIF1A—uterus—germ cell cancer	0.00101	0.00487	CbGeAlD
Carvedilol—SELE—adrenal gland—germ cell cancer	0.000997	0.00482	CbGeAlD
Carvedilol—VCAM1—medulla oblongata—germ cell cancer	0.000991	0.00479	CbGeAlD
Carvedilol—HIF1A—pituitary gland—germ cell cancer	0.000988	0.00478	CbGeAlD
Carvedilol—CYP2E1—urine—germ cell cancer	0.000987	0.00477	CbGeAlD
Carvedilol—SELE—midbrain—germ cell cancer	0.000985	0.00476	CbGeAlD
Carvedilol—GJA1—gonad—germ cell cancer	0.000982	0.00475	CbGeAlD
Carvedilol—GJA1—uterus—germ cell cancer	0.000976	0.00472	CbGeAlD
Carvedilol—NDUFC2—decidua—germ cell cancer	0.000971	0.0047	CbGeAlD
Carvedilol—SELE—spinal cord—germ cell cancer	0.000961	0.00465	CbGeAlD
Carvedilol—GJA1—pituitary gland—germ cell cancer	0.000958	0.00463	CbGeAlD
Carvedilol—HIF1A—medulla oblongata—germ cell cancer	0.000953	0.00461	CbGeAlD
Carvedilol—SELE—female gonad—germ cell cancer	0.00093	0.0045	CbGeAlD
Carvedilol—VEGFA—telencephalon—germ cell cancer	0.000929	0.00449	CbGeAlD
Carvedilol—GJA1—medulla oblongata—germ cell cancer	0.000925	0.00447	CbGeAlD
Carvedilol—VCAM1—adrenal gland—germ cell cancer	0.000917	0.00444	CbGeAlD
Carvedilol—NPPB—brain—germ cell cancer	0.000916	0.00443	CbGeAlD
Carvedilol—VCAM1—midbrain—germ cell cancer	0.000906	0.00438	CbGeAlD
Carvedilol—VCAM1—bone marrow—germ cell cancer	0.000887	0.00429	CbGeAlD
Carvedilol—VCAM1—spinal cord—germ cell cancer	0.000884	0.00427	CbGeAlD
Carvedilol—HIF1A—adrenal gland—germ cell cancer	0.000883	0.00427	CbGeAlD
Carvedilol—VEGFA—decidua—germ cell cancer	0.000881	0.00426	CbGeAlD
Carvedilol—CYP1A1—skin epidermis—germ cell cancer	0.000876	0.00424	CbGeAlD
Carvedilol—HIF1A—midbrain—germ cell cancer	0.000871	0.00421	CbGeAlD
Carvedilol—SELE—endocrine gland—germ cell cancer	0.000865	0.00418	CbGeAlD
Carvedilol—GJA1—adrenal gland—germ cell cancer	0.000856	0.00414	CbGeAlD
Carvedilol—VCAM1—female gonad—germ cell cancer	0.000855	0.00414	CbGeAlD
Carvedilol—NDUFC2—gonad—germ cell cancer	0.000855	0.00414	CbGeAlD
Carvedilol—HIF1A—bone marrow—germ cell cancer	0.000854	0.00413	CbGeAlD
Carvedilol—SELE—head—germ cell cancer	0.000854	0.00413	CbGeAlD
Carvedilol—HIF1A—spinal cord—germ cell cancer	0.00085	0.00411	CbGeAlD
Carvedilol—NDUFC2—uterus—germ cell cancer	0.000849	0.00411	CbGeAlD
Carvedilol—GJA1—midbrain—germ cell cancer	0.000845	0.00409	CbGeAlD
Carvedilol—NDUFC2—pituitary gland—germ cell cancer	0.000834	0.00403	CbGeAlD
Carvedilol—GJA1—bone marrow—germ cell cancer	0.000828	0.00401	CbGeAlD
Carvedilol—SELE—testis—germ cell cancer	0.000825	0.00399	CbGeAlD
Carvedilol—GJA1—spinal cord—germ cell cancer	0.000825	0.00399	CbGeAlD
Carvedilol—HIF1A—female gonad—germ cell cancer	0.000823	0.00398	CbGeAlD
Carvedilol—NDUFC2—medulla oblongata—germ cell cancer	0.000805	0.00389	CbGeAlD
Carvedilol—GJA1—female gonad—germ cell cancer	0.000798	0.00386	CbGeAlD
Carvedilol—VCAM1—endocrine gland—germ cell cancer	0.000795	0.00385	CbGeAlD
Carvedilol—CYP3A4—urine—germ cell cancer	0.000794	0.00384	CbGeAlD
Carvedilol—VCAM1—head—germ cell cancer	0.000785	0.0038	CbGeAlD
Carvedilol—CYP2D6—urine—germ cell cancer	0.000781	0.00378	CbGeAlD
Carvedilol—VEGFA—uterus—germ cell cancer	0.000771	0.00373	CbGeAlD
Carvedilol—HIF1A—endocrine gland—germ cell cancer	0.000765	0.0037	CbGeAlD
Carvedilol—SELE—cerebellum—germ cell cancer	0.000762	0.00368	CbGeAlD
Carvedilol—VCAM1—testis—germ cell cancer	0.000759	0.00367	CbGeAlD
Carvedilol—VEGFA—pituitary gland—germ cell cancer	0.000757	0.00366	CbGeAlD
Carvedilol—HIF1A—head—germ cell cancer	0.000756	0.00365	CbGeAlD
Carvedilol—NDUFC2—adrenal gland—germ cell cancer	0.000745	0.0036	CbGeAlD
Carvedilol—GJA1—endocrine gland—germ cell cancer	0.000742	0.00359	CbGeAlD
Carvedilol—NDUFC2—midbrain—germ cell cancer	0.000736	0.00356	CbGeAlD
Carvedilol—GJA1—head—germ cell cancer	0.000733	0.00354	CbGeAlD
Carvedilol—ADRB3—female gonad—germ cell cancer	0.000732	0.00354	CbGeAlD
Carvedilol—HIF1A—testis—germ cell cancer	0.00073	0.00353	CbGeAlD
Carvedilol—NDUFC2—bone marrow—germ cell cancer	0.000721	0.00349	CbGeAlD
Carvedilol—NDUFC2—spinal cord—germ cell cancer	0.000718	0.00347	CbGeAlD
Carvedilol—GJA1—testis—germ cell cancer	0.000708	0.00342	CbGeAlD
Carvedilol—NDUFC2—female gonad—germ cell cancer	0.000695	0.00336	CbGeAlD
Carvedilol—VEGFA—adrenal gland—germ cell cancer	0.000676	0.00327	CbGeAlD
Carvedilol—HIF1A—cerebellum—germ cell cancer	0.000674	0.00326	CbGeAlD
Carvedilol—VEGFA—bone marrow—germ cell cancer	0.000654	0.00316	CbGeAlD
Carvedilol—GJA1—cerebellum—germ cell cancer	0.000654	0.00316	CbGeAlD
Carvedilol—VEGFA—spinal cord—germ cell cancer	0.000651	0.00315	CbGeAlD
Carvedilol—PTGS1—ganglion—germ cell cancer	0.000648	0.00313	CbGeAlD
Carvedilol—NDUFC2—endocrine gland—germ cell cancer	0.000646	0.00313	CbGeAlD
Carvedilol—NDUFC2—head—germ cell cancer	0.000638	0.00309	CbGeAlD
Carvedilol—VEGFA—female gonad—germ cell cancer	0.00063	0.00305	CbGeAlD
Carvedilol—SELE—brain—germ cell cancer	0.000619	0.00299	CbGeAlD
Carvedilol—NDUFC2—testis—germ cell cancer	0.000616	0.00298	CbGeAlD
Carvedilol—ADRA1D—telencephalon—germ cell cancer	0.000607	0.00294	CbGeAlD
Carvedilol—SELE—lymph node—germ cell cancer	0.000598	0.00289	CbGeAlD
Carvedilol—NDUFC2—cerebellum—germ cell cancer	0.000569	0.00275	CbGeAlD
Carvedilol—VCAM1—brain—germ cell cancer	0.000569	0.00275	CbGeAlD
Carvedilol—VEGFA—testis—germ cell cancer	0.000559	0.0027	CbGeAlD
Carvedilol—PTGS1—endothelium—germ cell cancer	0.000559	0.0027	CbGeAlD
Carvedilol—VCAM1—lymph node—germ cell cancer	0.00055	0.00266	CbGeAlD
Carvedilol—HIF1A—brain—germ cell cancer	0.000547	0.00265	CbGeAlD
Carvedilol—GJA1—brain—germ cell cancer	0.000531	0.00257	CbGeAlD
Carvedilol—HIF1A—lymph node—germ cell cancer	0.000529	0.00256	CbGeAlD
Carvedilol—XDH—endocrine gland—germ cell cancer	0.000522	0.00252	CbGeAlD
Carvedilol—VEGFA—cerebellum—germ cell cancer	0.000516	0.0025	CbGeAlD
Carvedilol—PTGS1—blood vessel—germ cell cancer	0.000515	0.00249	CbGeAlD
Carvedilol—GJA1—lymph node—germ cell cancer	0.000513	0.00248	CbGeAlD
Carvedilol—NDUFC2—brain—germ cell cancer	0.000462	0.00224	CbGeAlD
Carvedilol—NDUFC2—lymph node—germ cell cancer	0.000447	0.00216	CbGeAlD
Carvedilol—ADRB1—telencephalon—germ cell cancer	0.000441	0.00213	CbGeAlD
Carvedilol—KCNH2—trigeminal ganglion—germ cell cancer	0.000429	0.00207	CbGeAlD
Carvedilol—ADRA2C—trigeminal ganglion—germ cell cancer	0.000423	0.00205	CbGeAlD
Carvedilol—VEGFA—brain—germ cell cancer	0.000419	0.00203	CbGeAlD
Carvedilol—VEGFA—lymph node—germ cell cancer	0.000405	0.00196	CbGeAlD
Carvedilol—ADRA1A—brainstem—germ cell cancer	0.000393	0.0019	CbGeAlD
Carvedilol—ADRA1B—head—germ cell cancer	0.000387	0.00187	CbGeAlD
Carvedilol—ADRA1D—endocrine gland—germ cell cancer	0.000383	0.00185	CbGeAlD
Carvedilol—ADRA1D—head—germ cell cancer	0.000378	0.00183	CbGeAlD
Carvedilol—ADRA1A—telencephalon—germ cell cancer	0.000349	0.00169	CbGeAlD
Carvedilol—Leukopenia—Ifosfamide—germ cell cancer	0.000341	0.00177	CcSEcCtD
Carvedilol—Immune system disorder—Cisplatin—germ cell cancer	0.000341	0.00177	CcSEcCtD
Carvedilol—Abdominal pain—Vinblastine—germ cell cancer	0.000341	0.00177	CcSEcCtD
Carvedilol—Mediastinal disorder—Cisplatin—germ cell cancer	0.00034	0.00177	CcSEcCtD
Carvedilol—Hypotension—Bleomycin—germ cell cancer	0.00034	0.00177	CcSEcCtD
Carvedilol—Oedema—Dactinomycin—germ cell cancer	0.000339	0.00176	CcSEcCtD
Carvedilol—Urethral disorder—Etoposide—germ cell cancer	0.000339	0.00176	CcSEcCtD
Carvedilol—ADRA2A—trigeminal ganglion—germ cell cancer	0.000338	0.00163	CbGeAlD
Carvedilol—Infection—Dactinomycin—germ cell cancer	0.000337	0.00175	CcSEcCtD
Carvedilol—KCNH2—telencephalon—germ cell cancer	0.000337	0.00163	CbGeAlD
Carvedilol—Palpitations—Ifosfamide—germ cell cancer	0.000337	0.00175	CcSEcCtD
Carvedilol—Alopecia—Cisplatin—germ cell cancer	0.000333	0.00173	CcSEcCtD
Carvedilol—Cough—Ifosfamide—germ cell cancer	0.000333	0.00173	CcSEcCtD
Carvedilol—ADRA2C—telencephalon—germ cell cancer	0.000332	0.00161	CbGeAlD
Carvedilol—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000332	0.00173	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000332	0.00172	CcSEcCtD
Carvedilol—Convulsion—Ifosfamide—germ cell cancer	0.00033	0.00172	CcSEcCtD
Carvedilol—Hypertension—Ifosfamide—germ cell cancer	0.000329	0.00171	CcSEcCtD
Carvedilol—Malnutrition—Cisplatin—germ cell cancer	0.000328	0.00171	CcSEcCtD
Carvedilol—Erythema multiforme—Etoposide—germ cell cancer	0.000327	0.0017	CcSEcCtD
Carvedilol—Paraesthesia—Bleomycin—germ cell cancer	0.000327	0.0017	CcSEcCtD
Carvedilol—Dyspnoea—Bleomycin—germ cell cancer	0.000324	0.00169	CcSEcCtD
Carvedilol—Myalgia—Ifosfamide—germ cell cancer	0.000324	0.00169	CcSEcCtD
Carvedilol—Chest pain—Ifosfamide—germ cell cancer	0.000324	0.00169	CcSEcCtD
Carvedilol—Arthralgia—Ifosfamide—germ cell cancer	0.000324	0.00169	CcSEcCtD
Carvedilol—Renal failure acute—Methotrexate—germ cell cancer	0.000324	0.00169	CcSEcCtD
Carvedilol—Flatulence—Cisplatin—germ cell cancer	0.000324	0.00168	CcSEcCtD
Carvedilol—Anorexia—Dactinomycin—germ cell cancer	0.000323	0.00168	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000322	0.00168	CcSEcCtD
Carvedilol—Discomfort—Ifosfamide—germ cell cancer	0.000321	0.00167	CcSEcCtD
Carvedilol—Hypersensitivity—Vinblastine—germ cell cancer	0.000317	0.00165	CcSEcCtD
Carvedilol—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000317	0.00165	CcSEcCtD
Carvedilol—Decreased appetite—Bleomycin—germ cell cancer	0.000316	0.00164	CcSEcCtD
Carvedilol—Muscle spasms—Cisplatin—germ cell cancer	0.000316	0.00164	CcSEcCtD
Carvedilol—ADRA2C—decidua—germ cell cancer	0.000315	0.00152	CbGeAlD
Carvedilol—Angiopathy—Etoposide—germ cell cancer	0.000314	0.00163	CcSEcCtD
Carvedilol—Confusional state—Ifosfamide—germ cell cancer	0.000314	0.00163	CcSEcCtD
Carvedilol—Immune system disorder—Etoposide—germ cell cancer	0.000312	0.00162	CcSEcCtD
Carvedilol—Mediastinal disorder—Etoposide—germ cell cancer	0.000312	0.00162	CcSEcCtD
Carvedilol—Pain—Bleomycin—germ cell cancer	0.000311	0.00162	CcSEcCtD
Carvedilol—Oedema—Ifosfamide—germ cell cancer	0.000311	0.00162	CcSEcCtD
Carvedilol—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000311	0.00162	CcSEcCtD
Carvedilol—Vision blurred—Cisplatin—germ cell cancer	0.00031	0.00161	CcSEcCtD
Carvedilol—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000309	0.00161	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000309	0.00161	CcSEcCtD
Carvedilol—Asthenia—Vinblastine—germ cell cancer	0.000309	0.00161	CcSEcCtD
Carvedilol—Infection—Ifosfamide—germ cell cancer	0.000309	0.00161	CcSEcCtD
Carvedilol—Alopecia—Etoposide—germ cell cancer	0.000305	0.00159	CcSEcCtD
Carvedilol—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000305	0.00159	CcSEcCtD
Carvedilol—Ill-defined disorder—Cisplatin—germ cell cancer	0.000305	0.00159	CcSEcCtD
Carvedilol—ABCB1—blood vessel—germ cell cancer	0.000305	0.00147	CbGeAlD
Carvedilol—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000304	0.00158	CcSEcCtD
Carvedilol—Anaemia—Cisplatin—germ cell cancer	0.000304	0.00158	CcSEcCtD
Carvedilol—Skin disorder—Ifosfamide—germ cell cancer	0.000302	0.00157	CcSEcCtD
Carvedilol—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000301	0.00156	CcSEcCtD
Carvedilol—Feeling abnormal—Bleomycin—germ cell cancer	0.0003	0.00156	CcSEcCtD
Carvedilol—Anorexia—Ifosfamide—germ cell cancer	0.000296	0.00154	CcSEcCtD
Carvedilol—Malaise—Cisplatin—germ cell cancer	0.000296	0.00154	CcSEcCtD
Carvedilol—Decreased appetite—Dactinomycin—germ cell cancer	0.000295	0.00153	CcSEcCtD
Carvedilol—Diarrhoea—Vinblastine—germ cell cancer	0.000295	0.00153	CcSEcCtD
Carvedilol—Leukopenia—Cisplatin—germ cell cancer	0.000294	0.00153	CcSEcCtD
Carvedilol—Fatigue—Dactinomycin—germ cell cancer	0.000293	0.00152	CcSEcCtD
Carvedilol—Back pain—Etoposide—germ cell cancer	0.000291	0.00151	CcSEcCtD
Carvedilol—Hypotension—Ifosfamide—germ cell cancer	0.000291	0.00151	CcSEcCtD
Carvedilol—Pain—Dactinomycin—germ cell cancer	0.00029	0.00151	CcSEcCtD
Carvedilol—Muscle spasms—Etoposide—germ cell cancer	0.000289	0.0015	CcSEcCtD
Carvedilol—Urticaria—Bleomycin—germ cell cancer	0.000289	0.0015	CcSEcCtD
Carvedilol—Body temperature increased—Bleomycin—germ cell cancer	0.000288	0.0015	CcSEcCtD
Carvedilol—Dizziness—Vinblastine—germ cell cancer	0.000285	0.00148	CcSEcCtD
Carvedilol—Convulsion—Cisplatin—germ cell cancer	0.000285	0.00148	CcSEcCtD
Carvedilol—Mood swings—Methotrexate—germ cell cancer	0.000284	0.00147	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000283	0.00147	CcSEcCtD
Carvedilol—ADRA1B—brain—germ cell cancer	0.00028	0.00135	CbGeAlD
Carvedilol—Myalgia—Cisplatin—germ cell cancer	0.00028	0.00145	CcSEcCtD
Carvedilol—Feeling abnormal—Dactinomycin—germ cell cancer	0.00028	0.00145	CcSEcCtD
Carvedilol—KCNH2—uterus—germ cell cancer	0.000279	0.00135	CbGeAlD
Carvedilol—Paraesthesia—Ifosfamide—germ cell cancer	0.000279	0.00145	CcSEcCtD
Carvedilol—Ill-defined disorder—Etoposide—germ cell cancer	0.000279	0.00145	CcSEcCtD
Carvedilol—ADRB1—endocrine gland—germ cell cancer	0.000278	0.00135	CbGeAlD
Carvedilol—Anaemia—Etoposide—germ cell cancer	0.000278	0.00145	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000278	0.00144	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000278	0.00144	CcSEcCtD
Carvedilol—Dyspnoea—Ifosfamide—germ cell cancer	0.000277	0.00144	CcSEcCtD
Carvedilol—Somnolence—Ifosfamide—germ cell cancer	0.000276	0.00144	CcSEcCtD
Carvedilol—Discomfort—Cisplatin—germ cell cancer	0.000276	0.00144	CcSEcCtD
Carvedilol—ADRA2C—uterus—germ cell cancer	0.000276	0.00133	CbGeAlD
Carvedilol—ADRB1—head—germ cell cancer	0.000275	0.00133	CbGeAlD
Carvedilol—KCNH2—pituitary gland—germ cell cancer	0.000274	0.00133	CbGeAlD
Carvedilol—ADRA1D—brain—germ cell cancer	0.000274	0.00133	CbGeAlD
Carvedilol—Vomiting—Vinblastine—germ cell cancer	0.000274	0.00142	CcSEcCtD
Carvedilol—CYP1A1—skin of body—germ cell cancer	0.000271	0.00131	CbGeAlD
Carvedilol—Malaise—Etoposide—germ cell cancer	0.000271	0.00141	CcSEcCtD
Carvedilol—ADRA2C—pituitary gland—germ cell cancer	0.000271	0.00131	CbGeAlD
Carvedilol—Vertigo—Etoposide—germ cell cancer	0.00027	0.00141	CcSEcCtD
Carvedilol—Decreased appetite—Ifosfamide—germ cell cancer	0.00027	0.00141	CcSEcCtD
Carvedilol—Headache—Vinblastine—germ cell cancer	0.00027	0.0014	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00027	0.0014	CcSEcCtD
Carvedilol—Leukopenia—Etoposide—germ cell cancer	0.000269	0.0014	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000268	0.0014	CcSEcCtD
Carvedilol—Abdominal pain—Dactinomycin—germ cell cancer	0.000268	0.0014	CcSEcCtD
Carvedilol—Body temperature increased—Dactinomycin—germ cell cancer	0.000268	0.0014	CcSEcCtD
Carvedilol—Fatigue—Ifosfamide—germ cell cancer	0.000268	0.00139	CcSEcCtD
Carvedilol—Oedema—Cisplatin—germ cell cancer	0.000268	0.00139	CcSEcCtD
Carvedilol—Anaphylactic shock—Cisplatin—germ cell cancer	0.000268	0.00139	CcSEcCtD
Carvedilol—Hypersensitivity—Bleomycin—germ cell cancer	0.000268	0.00139	CcSEcCtD
Carvedilol—Infection—Cisplatin—germ cell cancer	0.000266	0.00139	CcSEcCtD
Carvedilol—Constipation—Ifosfamide—germ cell cancer	0.000266	0.00138	CcSEcCtD
Carvedilol—Pain—Ifosfamide—germ cell cancer	0.000266	0.00138	CcSEcCtD
Carvedilol—ADRA2A—telencephalon—germ cell cancer	0.000265	0.00128	CbGeAlD
Carvedilol—KCNH2—medulla oblongata—germ cell cancer	0.000265	0.00128	CbGeAlD
Carvedilol—Loss of consciousness—Etoposide—germ cell cancer	0.000265	0.00138	CcSEcCtD
Carvedilol—Cough—Etoposide—germ cell cancer	0.000263	0.00137	CcSEcCtD
Carvedilol—Thrombocytopenia—Cisplatin—germ cell cancer	0.000262	0.00137	CcSEcCtD
Carvedilol—Tachycardia—Cisplatin—germ cell cancer	0.000262	0.00136	CcSEcCtD
Carvedilol—ADRA2C—medulla oblongata—germ cell cancer	0.000261	0.00126	CbGeAlD
Carvedilol—Asthenia—Bleomycin—germ cell cancer	0.000261	0.00136	CcSEcCtD
Carvedilol—Convulsion—Etoposide—germ cell cancer	0.000261	0.00136	CcSEcCtD
Carvedilol—Skin disorder—Cisplatin—germ cell cancer	0.00026	0.00135	CcSEcCtD
Carvedilol—Hypertension—Etoposide—germ cell cancer	0.00026	0.00135	CcSEcCtD
Carvedilol—CYP2E1—telencephalon—germ cell cancer	0.000259	0.00125	CbGeAlD
Carvedilol—Hyperhidrosis—Cisplatin—germ cell cancer	0.000259	0.00135	CcSEcCtD
Carvedilol—Pruritus—Bleomycin—germ cell cancer	0.000257	0.00134	CcSEcCtD
Carvedilol—Feeling abnormal—Ifosfamide—germ cell cancer	0.000256	0.00133	CcSEcCtD
Carvedilol—Chest pain—Etoposide—germ cell cancer	0.000256	0.00133	CcSEcCtD
Carvedilol—Nausea—Vinblastine—germ cell cancer	0.000256	0.00133	CcSEcCtD
Carvedilol—Anorexia—Cisplatin—germ cell cancer	0.000256	0.00133	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000254	0.00132	CcSEcCtD
Carvedilol—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000254	0.00132	CcSEcCtD
Carvedilol—ADRA1A—adrenal gland—germ cell cancer	0.000254	0.00123	CbGeAlD
Carvedilol—Discomfort—Etoposide—germ cell cancer	0.000253	0.00132	CcSEcCtD
Carvedilol—ADRA2A—decidua—germ cell cancer	0.000251	0.00122	CbGeAlD
Carvedilol—Hypotension—Cisplatin—germ cell cancer	0.000251	0.0013	CcSEcCtD
Carvedilol—Hypersensitivity—Dactinomycin—germ cell cancer	0.00025	0.0013	CcSEcCtD
Carvedilol—PTGS1—telencephalon—germ cell cancer	0.00025	0.00121	CbGeAlD
Carvedilol—Confusional state—Etoposide—germ cell cancer	0.000248	0.00129	CcSEcCtD
Carvedilol—Urticaria—Ifosfamide—germ cell cancer	0.000247	0.00128	CcSEcCtD
Carvedilol—Body temperature increased—Ifosfamide—germ cell cancer	0.000246	0.00128	CcSEcCtD
Carvedilol—Abdominal pain—Ifosfamide—germ cell cancer	0.000246	0.00128	CcSEcCtD
Carvedilol—Pancytopenia—Methotrexate—germ cell cancer	0.000246	0.00128	CcSEcCtD
Carvedilol—Anaphylactic shock—Etoposide—germ cell cancer	0.000246	0.00128	CcSEcCtD
Carvedilol—KCNH2—adrenal gland—germ cell cancer	0.000245	0.00118	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000244	0.00127	CcSEcCtD
Carvedilol—Infection—Etoposide—germ cell cancer	0.000244	0.00127	CcSEcCtD
Carvedilol—Asthenia—Dactinomycin—germ cell cancer	0.000243	0.00127	CcSEcCtD
Carvedilol—KCNH2—midbrain—germ cell cancer	0.000242	0.00117	CbGeAlD
Carvedilol—ADRA2C—adrenal gland—germ cell cancer	0.000242	0.00117	CbGeAlD
Carvedilol—Paraesthesia—Cisplatin—germ cell cancer	0.000241	0.00125	CcSEcCtD
Carvedilol—Thrombocytopenia—Etoposide—germ cell cancer	0.00024	0.00125	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00024	0.00125	CcSEcCtD
Carvedilol—Tachycardia—Etoposide—germ cell cancer	0.00024	0.00125	CcSEcCtD
Carvedilol—Dyspnoea—Cisplatin—germ cell cancer	0.000239	0.00124	CcSEcCtD
Carvedilol—ADRA2C—midbrain—germ cell cancer	0.000239	0.00115	CbGeAlD
Carvedilol—Skin disorder—Etoposide—germ cell cancer	0.000239	0.00124	CcSEcCtD
Carvedilol—PTGS1—skin of body—germ cell cancer	0.000238	0.00115	CbGeAlD
Carvedilol—Erectile dysfunction—Methotrexate—germ cell cancer	0.000238	0.00124	CcSEcCtD
Carvedilol—Hyperhidrosis—Etoposide—germ cell cancer	0.000237	0.00123	CcSEcCtD
Carvedilol—KCNH2—bone marrow—germ cell cancer	0.000237	0.00115	CbGeAlD
Carvedilol—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000236	0.00123	CcSEcCtD
Carvedilol—KCNH2—spinal cord—germ cell cancer	0.000236	0.00114	CbGeAlD
Carvedilol—CYP1A1—uterus—germ cell cancer	0.000236	0.00114	CbGeAlD
Carvedilol—Anorexia—Etoposide—germ cell cancer	0.000234	0.00122	CcSEcCtD
Carvedilol—Decreased appetite—Cisplatin—germ cell cancer	0.000233	0.00121	CcSEcCtD
Carvedilol—ADRA2C—spinal cord—germ cell cancer	0.000233	0.00113	CbGeAlD
Carvedilol—Diarrhoea—Dactinomycin—germ cell cancer	0.000232	0.00121	CcSEcCtD
Carvedilol—Pneumonia—Methotrexate—germ cell cancer	0.000232	0.00121	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000231	0.0012	CcSEcCtD
Carvedilol—CYP2D6—brainstem—germ cell cancer	0.000231	0.00112	CbGeAlD
Carvedilol—Vomiting—Bleomycin—germ cell cancer	0.000231	0.0012	CcSEcCtD
Carvedilol—Depression—Methotrexate—germ cell cancer	0.00023	0.0012	CcSEcCtD
Carvedilol—Hypotension—Etoposide—germ cell cancer	0.00023	0.00119	CcSEcCtD
Carvedilol—Rash—Bleomycin—germ cell cancer	0.000229	0.00119	CcSEcCtD
Carvedilol—Pain—Cisplatin—germ cell cancer	0.000229	0.00119	CcSEcCtD
Carvedilol—Dermatitis—Bleomycin—germ cell cancer	0.000229	0.00119	CcSEcCtD
Carvedilol—Hypersensitivity—Ifosfamide—germ cell cancer	0.000229	0.00119	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000229	0.00119	CcSEcCtD
Carvedilol—KCNH2—female gonad—germ cell cancer	0.000228	0.0011	CbGeAlD
Carvedilol—Renal failure—Methotrexate—germ cell cancer	0.000227	0.00118	CcSEcCtD
Carvedilol—ADRA2C—female gonad—germ cell cancer	0.000225	0.00109	CbGeAlD
Carvedilol—Asthenia—Ifosfamide—germ cell cancer	0.000223	0.00116	CcSEcCtD
Carvedilol—ADRA2A—gonad—germ cell cancer	0.000221	0.00107	CbGeAlD
Carvedilol—Feeling abnormal—Cisplatin—germ cell cancer	0.000221	0.00115	CcSEcCtD
Carvedilol—Paraesthesia—Etoposide—germ cell cancer	0.000221	0.00115	CcSEcCtD
Carvedilol—Pruritus—Ifosfamide—germ cell cancer	0.00022	0.00114	CcSEcCtD
Carvedilol—ADRA1A—endocrine gland—germ cell cancer	0.00022	0.00106	CbGeAlD
Carvedilol—Haematuria—Methotrexate—germ cell cancer	0.00022	0.00114	CcSEcCtD
Carvedilol—ADRA2A—uterus—germ cell cancer	0.00022	0.00106	CbGeAlD
Carvedilol—Dyspnoea—Etoposide—germ cell cancer	0.000219	0.00114	CcSEcCtD
Carvedilol—Somnolence—Etoposide—germ cell cancer	0.000218	0.00114	CcSEcCtD
Carvedilol—ADRA1A—head—germ cell cancer	0.000217	0.00105	CbGeAlD
Carvedilol—Nausea—Bleomycin—germ cell cancer	0.000216	0.00112	CcSEcCtD
Carvedilol—ADRA2A—pituitary gland—germ cell cancer	0.000216	0.00104	CbGeAlD
Carvedilol—Vomiting—Dactinomycin—germ cell cancer	0.000216	0.00112	CcSEcCtD
Carvedilol—Rash—Dactinomycin—germ cell cancer	0.000214	0.00111	CcSEcCtD
Carvedilol—Decreased appetite—Etoposide—germ cell cancer	0.000214	0.00111	CcSEcCtD
Carvedilol—Diarrhoea—Ifosfamide—germ cell cancer	0.000213	0.00111	CcSEcCtD
Carvedilol—KCNH2—endocrine gland—germ cell cancer	0.000212	0.00103	CbGeAlD
Carvedilol—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000212	0.0011	CcSEcCtD
Carvedilol—Body temperature increased—Cisplatin—germ cell cancer	0.000212	0.0011	CcSEcCtD
Carvedilol—Fatigue—Etoposide—germ cell cancer	0.000212	0.0011	CcSEcCtD
Carvedilol—Pain—Etoposide—germ cell cancer	0.00021	0.00109	CcSEcCtD
Carvedilol—Constipation—Etoposide—germ cell cancer	0.00021	0.00109	CcSEcCtD
Carvedilol—KCNH2—head—germ cell cancer	0.00021	0.00101	CbGeAlD
Carvedilol—ADRA2A—medulla oblongata—germ cell cancer	0.000208	0.00101	CbGeAlD
Carvedilol—Haemoglobin—Methotrexate—germ cell cancer	0.000208	0.00108	CcSEcCtD
Carvedilol—PTGS1—uterus—germ cell cancer	0.000207	0.001	CbGeAlD
Carvedilol—Haemorrhage—Methotrexate—germ cell cancer	0.000207	0.00108	CcSEcCtD
Carvedilol—ADRA2C—head—germ cell cancer	0.000207	0.001	CbGeAlD
Carvedilol—Dizziness—Ifosfamide—germ cell cancer	0.000206	0.00107	CcSEcCtD
Carvedilol—Pharyngitis—Methotrexate—germ cell cancer	0.000206	0.00107	CcSEcCtD
Carvedilol—CYP2D6—telencephalon—germ cell cancer	0.000205	0.000993	CbGeAlD
Carvedilol—Urinary tract disorder—Methotrexate—germ cell cancer	0.000205	0.00106	CcSEcCtD
Carvedilol—CYP2E1—medulla oblongata—germ cell cancer	0.000204	0.000986	CbGeAlD
Carvedilol—PTGS1—pituitary gland—germ cell cancer	0.000203	0.000984	CbGeAlD
Carvedilol—Urethral disorder—Methotrexate—germ cell cancer	0.000203	0.00106	CcSEcCtD
Carvedilol—KCNH2—testis—germ cell cancer	0.000203	0.00098	CbGeAlD
Carvedilol—Feeling abnormal—Etoposide—germ cell cancer	0.000202	0.00105	CcSEcCtD
Carvedilol—Nausea—Dactinomycin—germ cell cancer	0.000202	0.00105	CcSEcCtD
Carvedilol—Gastrointestinal pain—Etoposide—germ cell cancer	0.000201	0.00104	CcSEcCtD
Carvedilol—ADRA2C—testis—germ cell cancer	0.0002	0.000967	CbGeAlD
Carvedilol—Visual impairment—Methotrexate—germ cell cancer	0.0002	0.00104	CcSEcCtD
Carvedilol—ADRB1—brain—germ cell cancer	0.000199	0.000962	CbGeAlD
Carvedilol—Vomiting—Ifosfamide—germ cell cancer	0.000198	0.00103	CcSEcCtD
Carvedilol—Hypersensitivity—Cisplatin—germ cell cancer	0.000198	0.00103	CcSEcCtD
Carvedilol—Rash—Ifosfamide—germ cell cancer	0.000196	0.00102	CcSEcCtD
Carvedilol—Dermatitis—Ifosfamide—germ cell cancer	0.000196	0.00102	CcSEcCtD
Carvedilol—Erythema multiforme—Methotrexate—germ cell cancer	0.000196	0.00102	CcSEcCtD
Carvedilol—Urticaria—Etoposide—germ cell cancer	0.000195	0.00101	CcSEcCtD
Carvedilol—Abdominal pain—Etoposide—germ cell cancer	0.000194	0.00101	CcSEcCtD
Carvedilol—Body temperature increased—Etoposide—germ cell cancer	0.000194	0.00101	CcSEcCtD
Carvedilol—ADRA1A—cerebellum—germ cell cancer	0.000194	0.000937	CbGeAlD
Carvedilol—Tinnitus—Methotrexate—germ cell cancer	0.000193	0.001	CcSEcCtD
Carvedilol—CYP1A1—female gonad—germ cell cancer	0.000193	0.000933	CbGeAlD
Carvedilol—ADRA2A—adrenal gland—germ cell cancer	0.000193	0.000933	CbGeAlD
Carvedilol—Asthenia—Cisplatin—germ cell cancer	0.000192	0.001	CcSEcCtD
Carvedilol—ADRA2A—midbrain—germ cell cancer	0.00019	0.000921	CbGeAlD
Carvedilol—CYP2E1—adrenal gland—germ cell cancer	0.000189	0.000912	CbGeAlD
Carvedilol—ABCB1—trigeminal ganglion—germ cell cancer	0.000188	0.00091	CbGeAlD
Carvedilol—Angiopathy—Methotrexate—germ cell cancer	0.000188	0.000977	CcSEcCtD
Carvedilol—KCNH2—cerebellum—germ cell cancer	0.000187	0.000905	CbGeAlD
Carvedilol—Immune system disorder—Methotrexate—germ cell cancer	0.000187	0.000973	CcSEcCtD
Carvedilol—Mediastinal disorder—Methotrexate—germ cell cancer	0.000187	0.000971	CcSEcCtD
Carvedilol—ADRA2A—spinal cord—germ cell cancer	0.000186	0.000898	CbGeAlD
Carvedilol—Nausea—Ifosfamide—germ cell cancer	0.000185	0.000961	CcSEcCtD
Carvedilol—ADRA2C—cerebellum—germ cell cancer	0.000185	0.000893	CbGeAlD
Carvedilol—Diarrhoea—Cisplatin—germ cell cancer	0.000183	0.000954	CcSEcCtD
Carvedilol—Alopecia—Methotrexate—germ cell cancer	0.000183	0.000952	CcSEcCtD
Carvedilol—CYP1A2—endocrine gland—germ cell cancer	0.000182	0.00088	CbGeAlD
Carvedilol—PTGS1—adrenal gland—germ cell cancer	0.000182	0.000879	CbGeAlD
Carvedilol—CYP2E1—spinal cord—germ cell cancer	0.000182	0.000879	CbGeAlD
Carvedilol—ABCB1—embryo—germ cell cancer	0.000182	0.000879	CbGeAlD
Carvedilol—Hypersensitivity—Etoposide—germ cell cancer	0.000181	0.000941	CcSEcCtD
Carvedilol—Malnutrition—Methotrexate—germ cell cancer	0.00018	0.000937	CcSEcCtD
Carvedilol—ADRA2A—female gonad—germ cell cancer	0.00018	0.00087	CbGeAlD
Carvedilol—CYP1A1—endocrine gland—germ cell cancer	0.000179	0.000868	CbGeAlD
Carvedilol—CYP1A1—head—germ cell cancer	0.000177	0.000857	CbGeAlD
Carvedilol—Asthenia—Etoposide—germ cell cancer	0.000176	0.000916	CcSEcCtD
Carvedilol—PTGS1—spinal cord—germ cell cancer	0.000175	0.000847	CbGeAlD
Carvedilol—Back pain—Methotrexate—germ cell cancer	0.000174	0.000907	CcSEcCtD
Carvedilol—Pruritus—Etoposide—germ cell cancer	0.000174	0.000904	CcSEcCtD
Carvedilol—CYP2C9—endocrine gland—germ cell cancer	0.000173	0.000835	CbGeAlD
Carvedilol—Vomiting—Cisplatin—germ cell cancer	0.00017	0.000886	CcSEcCtD
Carvedilol—Vision blurred—Methotrexate—germ cell cancer	0.00017	0.000883	CcSEcCtD
Carvedilol—PTGS1—female gonad—germ cell cancer	0.000169	0.00082	CbGeAlD
Carvedilol—Rash—Cisplatin—germ cell cancer	0.000169	0.000879	CcSEcCtD
Carvedilol—Dermatitis—Cisplatin—germ cell cancer	0.000169	0.000878	CcSEcCtD
Carvedilol—Diarrhoea—Etoposide—germ cell cancer	0.000168	0.000874	CcSEcCtD
Carvedilol—Ill-defined disorder—Methotrexate—germ cell cancer	0.000167	0.00087	CcSEcCtD
Carvedilol—ADRA2A—endocrine gland—germ cell cancer	0.000167	0.000809	CbGeAlD
Carvedilol—Anaemia—Methotrexate—germ cell cancer	0.000167	0.000866	CcSEcCtD
Carvedilol—ADRA2A—head—germ cell cancer	0.000165	0.000799	CbGeAlD
Carvedilol—CYP2E1—endocrine gland—germ cell cancer	0.000164	0.000791	CbGeAlD
Carvedilol—Malaise—Methotrexate—germ cell cancer	0.000163	0.000845	CcSEcCtD
Carvedilol—Dizziness—Etoposide—germ cell cancer	0.000162	0.000845	CcSEcCtD
Carvedilol—Vertigo—Methotrexate—germ cell cancer	0.000162	0.000842	CcSEcCtD
Carvedilol—CYP2E1—head—germ cell cancer	0.000162	0.000781	CbGeAlD
Carvedilol—Leukopenia—Methotrexate—germ cell cancer	0.000161	0.000839	CcSEcCtD
Carvedilol—ABCB1—retina—germ cell cancer	0.000161	0.000777	CbGeAlD
Carvedilol—ADRA2A—testis—germ cell cancer	0.000159	0.000771	CbGeAlD
Carvedilol—Nausea—Cisplatin—germ cell cancer	0.000159	0.000828	CcSEcCtD
Carvedilol—PTGS1—endocrine gland—germ cell cancer	0.000158	0.000762	CbGeAlD
Carvedilol—ADRA1A—brain—germ cell cancer	0.000157	0.000761	CbGeAlD
Carvedilol—Cough—Methotrexate—germ cell cancer	0.000157	0.000818	CcSEcCtD
Carvedilol—Convulsion—Methotrexate—germ cell cancer	0.000156	0.000812	CcSEcCtD
Carvedilol—Vomiting—Etoposide—germ cell cancer	0.000156	0.000812	CcSEcCtD
Carvedilol—CYP2E1—testis—germ cell cancer	0.000156	0.000755	CbGeAlD
Carvedilol—PTGS1—head—germ cell cancer	0.000156	0.000753	CbGeAlD
Carvedilol—Rash—Etoposide—germ cell cancer	0.000155	0.000805	CcSEcCtD
Carvedilol—Dermatitis—Etoposide—germ cell cancer	0.000155	0.000805	CcSEcCtD
Carvedilol—Headache—Etoposide—germ cell cancer	0.000154	0.0008	CcSEcCtD
Carvedilol—Chest pain—Methotrexate—germ cell cancer	0.000153	0.000798	CcSEcCtD
Carvedilol—Myalgia—Methotrexate—germ cell cancer	0.000153	0.000798	CcSEcCtD
Carvedilol—Arthralgia—Methotrexate—germ cell cancer	0.000153	0.000798	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000152	0.000793	CcSEcCtD
Carvedilol—KCNH2—brain—germ cell cancer	0.000152	0.000735	CbGeAlD
Carvedilol—Discomfort—Methotrexate—germ cell cancer	0.000152	0.000789	CcSEcCtD
Carvedilol—PTGS1—testis—germ cell cancer	0.00015	0.000727	CbGeAlD
Carvedilol—ADRA2C—brain—germ cell cancer	0.00015	0.000725	CbGeAlD
Carvedilol—Confusional state—Methotrexate—germ cell cancer	0.000148	0.000771	CcSEcCtD
Carvedilol—ABCB1—telencephalon—germ cell cancer	0.000148	0.000715	CbGeAlD
Carvedilol—ADRA2A—cerebellum—germ cell cancer	0.000147	0.000712	CbGeAlD
Carvedilol—Anaphylactic shock—Methotrexate—germ cell cancer	0.000147	0.000765	CcSEcCtD
Carvedilol—KCNH2—lymph node—germ cell cancer	0.000147	0.00071	CbGeAlD
Carvedilol—Infection—Methotrexate—germ cell cancer	0.000146	0.00076	CcSEcCtD
Carvedilol—Nausea—Etoposide—germ cell cancer	0.000146	0.000759	CcSEcCtD
Carvedilol—ADRA2C—lymph node—germ cell cancer	0.000145	0.000701	CbGeAlD
Carvedilol—CYP2E1—cerebellum—germ cell cancer	0.000144	0.000697	CbGeAlD
Carvedilol—Thrombocytopenia—Methotrexate—germ cell cancer	0.000144	0.000749	CcSEcCtD
Carvedilol—Skin disorder—Methotrexate—germ cell cancer	0.000143	0.000743	CcSEcCtD
Carvedilol—Hyperhidrosis—Methotrexate—germ cell cancer	0.000142	0.00074	CcSEcCtD
Carvedilol—Anorexia—Methotrexate—germ cell cancer	0.00014	0.000729	CcSEcCtD
Carvedilol—ABCB1—decidua—germ cell cancer	0.00014	0.000677	CbGeAlD
Carvedilol—CYP2D6—female gonad—germ cell cancer	0.000139	0.000674	CbGeAlD
Carvedilol—Hypotension—Methotrexate—germ cell cancer	0.000137	0.000715	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000134	0.000697	CcSEcCtD
Carvedilol—Insomnia—Methotrexate—germ cell cancer	0.000133	0.000692	CcSEcCtD
Carvedilol—Paraesthesia—Methotrexate—germ cell cancer	0.000132	0.000687	CcSEcCtD
Carvedilol—CYP3A4—endocrine gland—germ cell cancer	0.000132	0.000637	CbGeAlD
Carvedilol—Dyspnoea—Methotrexate—germ cell cancer	0.000131	0.000682	CcSEcCtD
Carvedilol—Somnolence—Methotrexate—germ cell cancer	0.000131	0.00068	CcSEcCtD
Carvedilol—CYP2D6—endocrine gland—germ cell cancer	0.00013	0.000627	CbGeAlD
Carvedilol—Dyspepsia—Methotrexate—germ cell cancer	0.00013	0.000673	CcSEcCtD
Carvedilol—CYP1A1—brain—germ cell cancer	0.000128	0.000621	CbGeAlD
Carvedilol—CYP2D6—head—germ cell cancer	0.000128	0.000619	CbGeAlD
Carvedilol—Decreased appetite—Methotrexate—germ cell cancer	0.000128	0.000665	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000127	0.000661	CcSEcCtD
Carvedilol—Fatigue—Methotrexate—germ cell cancer	0.000127	0.00066	CcSEcCtD
Carvedilol—Pain—Methotrexate—germ cell cancer	0.000126	0.000654	CcSEcCtD
Carvedilol—CYP1A1—lymph node—germ cell cancer	0.000124	0.0006	CbGeAlD
Carvedilol—CYP2D6—testis—germ cell cancer	0.000124	0.000598	CbGeAlD
Carvedilol—ABCB1—gonad—germ cell cancer	0.000123	0.000596	CbGeAlD
Carvedilol—ABCB1—uterus—germ cell cancer	0.000122	0.000592	CbGeAlD
Carvedilol—Feeling abnormal—Methotrexate—germ cell cancer	0.000121	0.00063	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00012	0.000626	CcSEcCtD
Carvedilol—ABCB1—pituitary gland—germ cell cancer	0.00012	0.000582	CbGeAlD
Carvedilol—ADRA2A—brain—germ cell cancer	0.00012	0.000579	CbGeAlD
Carvedilol—CYP2E1—brain—germ cell cancer	0.000117	0.000566	CbGeAlD
Carvedilol—Urticaria—Methotrexate—germ cell cancer	0.000117	0.000608	CcSEcCtD
Carvedilol—Abdominal pain—Methotrexate—germ cell cancer	0.000116	0.000605	CcSEcCtD
Carvedilol—Body temperature increased—Methotrexate—germ cell cancer	0.000116	0.000605	CcSEcCtD
Carvedilol—ABCB1—medulla oblongata—germ cell cancer	0.000116	0.000561	CbGeAlD
Carvedilol—ADRA2A—lymph node—germ cell cancer	0.000116	0.000559	CbGeAlD
Carvedilol—CYP2D6—cerebellum—germ cell cancer	0.000114	0.000552	CbGeAlD
Carvedilol—PTGS1—brain—germ cell cancer	0.000113	0.000545	CbGeAlD
Carvedilol—PTGS1—lymph node—germ cell cancer	0.000109	0.000527	CbGeAlD
Carvedilol—Hypersensitivity—Methotrexate—germ cell cancer	0.000108	0.000564	CcSEcCtD
Carvedilol—ABCB1—adrenal gland—germ cell cancer	0.000107	0.00052	CbGeAlD
Carvedilol—ABCB1—midbrain—germ cell cancer	0.000106	0.000513	CbGeAlD
Carvedilol—Asthenia—Methotrexate—germ cell cancer	0.000106	0.000549	CcSEcCtD
Carvedilol—Pruritus—Methotrexate—germ cell cancer	0.000104	0.000541	CcSEcCtD
Carvedilol—ABCB1—bone marrow—germ cell cancer	0.000104	0.000503	CbGeAlD
Carvedilol—ABCB1—spinal cord—germ cell cancer	0.000104	0.000501	CbGeAlD
Carvedilol—Diarrhoea—Methotrexate—germ cell cancer	0.000101	0.000523	CcSEcCtD
Carvedilol—ABCB1—female gonad—germ cell cancer	0.0001	0.000485	CbGeAlD
Carvedilol—Dizziness—Methotrexate—germ cell cancer	9.73e-05	0.000506	CcSEcCtD
Carvedilol—Vomiting—Methotrexate—germ cell cancer	9.35e-05	0.000486	CcSEcCtD
Carvedilol—ABCB1—endocrine gland—germ cell cancer	9.32e-05	0.000451	CbGeAlD
Carvedilol—Rash—Methotrexate—germ cell cancer	9.28e-05	0.000482	CcSEcCtD
Carvedilol—CYP2D6—brain—germ cell cancer	9.27e-05	0.000448	CbGeAlD
Carvedilol—Dermatitis—Methotrexate—germ cell cancer	9.27e-05	0.000482	CcSEcCtD
Carvedilol—Headache—Methotrexate—germ cell cancer	9.22e-05	0.000479	CcSEcCtD
Carvedilol—ABCB1—head—germ cell cancer	9.2e-05	0.000445	CbGeAlD
Carvedilol—ABCB1—testis—germ cell cancer	8.89e-05	0.00043	CbGeAlD
Carvedilol—Nausea—Methotrexate—germ cell cancer	8.74e-05	0.000454	CcSEcCtD
Carvedilol—ABCB1—cerebellum—germ cell cancer	8.21e-05	0.000397	CbGeAlD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	8.1e-05	0.00114	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—KIT—germ cell cancer	8.09e-05	0.00113	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	8.07e-05	0.00113	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—OXT—germ cell cancer	8.03e-05	0.00113	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—CD9—germ cell cancer	7.96e-05	0.00112	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—OXT—germ cell cancer	7.81e-05	0.0011	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—OXT—germ cell cancer	7.59e-05	0.00106	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.5e-05	0.00105	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—OXT—germ cell cancer	7.47e-05	0.00105	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—H2AFZ—germ cell cancer	7.39e-05	0.00104	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.38e-05	0.00104	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.36e-05	0.00103	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.32e-05	0.00103	CbGpPWpGaD
Carvedilol—ADRA1B—LPA receptor mediated events—HRAS—germ cell cancer	7.23e-05	0.00101	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.22e-05	0.00101	CbGpPWpGaD
Carvedilol—HIF1A—Disease—FGFR3—germ cell cancer	7.21e-05	0.00101	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—TP53—germ cell cancer	7.11e-05	0.000997	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—OXT—germ cell cancer	7.09e-05	0.000994	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.08e-05	0.000993	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—TP53—germ cell cancer	7.02e-05	0.000984	CbGpPWpGaD
Carvedilol—XDH—Metabolism—CRABP1—germ cell cancer	7e-05	0.000982	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	6.83e-05	0.000958	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—KITLG—germ cell cancer	6.79e-05	0.000953	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	6.73e-05	0.000943	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	6.72e-05	0.000943	CbGpPWpGaD
Carvedilol—ABCB1—brain—germ cell cancer	6.67e-05	0.000322	CbGeAlD
Carvedilol—HIF1A—Signaling Pathways—AVP—germ cell cancer	6.64e-05	0.000931	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—OXT—germ cell cancer	6.64e-05	0.000931	CbGpPWpGaD
Carvedilol—HIF1A—Disease—KIT—germ cell cancer	6.62e-05	0.000928	CbGpPWpGaD
Carvedilol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	6.5e-05	0.000911	CbGpPWpGaD
Carvedilol—ABCB1—lymph node—germ cell cancer	6.44e-05	0.000312	CbGeAlD
Carvedilol—ADRA1A—AMPK Signaling—TP53—germ cell cancer	6.32e-05	0.000886	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—AVP—germ cell cancer	6.17e-05	0.000865	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—OXT—germ cell cancer	6.17e-05	0.000865	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.97e-05	0.000838	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.81e-05	0.000815	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—HRAS—germ cell cancer	5.77e-05	0.000808	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—AVP—germ cell cancer	5.62e-05	0.000788	CbGpPWpGaD
Carvedilol—VEGFA—Focal Adhesion—HRAS—germ cell cancer	5.58e-05	0.000783	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—AVP—germ cell cancer	5.57e-05	0.000781	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.55e-05	0.000778	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—AVP—germ cell cancer	5.5e-05	0.000771	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	5.46e-05	0.000765	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—AVP—germ cell cancer	5.35e-05	0.000751	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—AVP—germ cell cancer	5.2e-05	0.00073	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.19e-05	0.000727	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—AVP—germ cell cancer	5.12e-05	0.000718	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—OXT—germ cell cancer	5.09e-05	0.000713	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—FGFR3—germ cell cancer	5.05e-05	0.000708	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.91e-05	0.000688	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—AVP—germ cell cancer	4.86e-05	0.000682	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.83e-05	0.000678	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—OXT—germ cell cancer	4.64e-05	0.00065	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—KIT—germ cell cancer	4.64e-05	0.00065	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—OXT—germ cell cancer	4.62e-05	0.000648	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—OXT—germ cell cancer	4.59e-05	0.000644	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—AVP—germ cell cancer	4.55e-05	0.000638	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—OXT—germ cell cancer	4.54e-05	0.000636	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—TP53—germ cell cancer	4.49e-05	0.000629	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—OXT—germ cell cancer	4.29e-05	0.000602	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	4.29e-05	0.000601	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—AVP—germ cell cancer	4.23e-05	0.000593	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—OXT—germ cell cancer	4.22e-05	0.000592	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—OXT—germ cell cancer	4.21e-05	0.00059	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—OXT—germ cell cancer	4.19e-05	0.000587	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—OXT—germ cell cancer	4.18e-05	0.000586	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—OXT—germ cell cancer	4.17e-05	0.000585	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—OXT—germ cell cancer	4.12e-05	0.000577	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC2A3—germ cell cancer	4.09e-05	0.000574	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC2A3—germ cell cancer	4.08e-05	0.000572	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC22A3—germ cell cancer	4.03e-05	0.000565	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC22A3—germ cell cancer	4.02e-05	0.000564	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—OXT—germ cell cancer	3.9e-05	0.000546	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.87e-05	0.000543	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—OXT—germ cell cancer	3.84e-05	0.000538	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—OXT—germ cell cancer	3.75e-05	0.000526	CbGpPWpGaD
Carvedilol—KCNH2—Neuronal System—HRAS—germ cell cancer	3.72e-05	0.000522	CbGpPWpGaD
Carvedilol—VEGFA—Axon guidance—HRAS—germ cell cancer	3.64e-05	0.000511	CbGpPWpGaD
Carvedilol—HIF1A—Disease—MYC—germ cell cancer	3.64e-05	0.000511	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF4—germ cell cancer	3.58e-05	0.000501	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF4—germ cell cancer	3.57e-05	0.0005	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HRAS—germ cell cancer	3.5e-05	0.00049	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AVP—germ cell cancer	3.49e-05	0.000489	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—OXT—germ cell cancer	3.49e-05	0.000489	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—OXT—germ cell cancer	3.41e-05	0.000478	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC2A3—germ cell cancer	3.32e-05	0.000466	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.31e-05	0.000464	CbGpPWpGaD
Carvedilol—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	3.3e-05	0.000463	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CRABP1—germ cell cancer	3.29e-05	0.000461	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CRABP1—germ cell cancer	3.28e-05	0.00046	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC22A3—germ cell cancer	3.27e-05	0.000459	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—H2AFZ—germ cell cancer	3.19e-05	0.000448	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—H2AFZ—germ cell cancer	3.19e-05	0.000447	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AVP—germ cell cancer	3.18e-05	0.000445	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AVP—germ cell cancer	3.17e-05	0.000444	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—OXT—germ cell cancer	3.17e-05	0.000444	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AVP—germ cell cancer	3.15e-05	0.000441	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AVP—germ cell cancer	3.11e-05	0.000436	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC2A3—germ cell cancer	3.05e-05	0.000428	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC22A3—germ cell cancer	3.01e-05	0.000421	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AVP—germ cell cancer	2.94e-05	0.000412	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—KITLG—germ cell cancer	2.94e-05	0.000412	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—KITLG—germ cell cancer	2.93e-05	0.000411	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AVP—germ cell cancer	2.89e-05	0.000406	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AVP—germ cell cancer	2.89e-05	0.000405	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC2A3—germ cell cancer	2.88e-05	0.000403	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AVP—germ cell cancer	2.87e-05	0.000403	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AVP—germ cell cancer	2.87e-05	0.000402	CbGpPWpGaD
Carvedilol—HIF1A—Disease—HRAS—germ cell cancer	2.86e-05	0.000401	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AVP—germ cell cancer	2.86e-05	0.000401	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC22A3—germ cell cancer	2.83e-05	0.000397	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AVP—germ cell cancer	2.82e-05	0.000396	CbGpPWpGaD
Carvedilol—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.74e-05	0.000384	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—OXT—germ cell cancer	2.73e-05	0.000383	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AVP—germ cell cancer	2.67e-05	0.000374	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CRABP1—germ cell cancer	2.67e-05	0.000374	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TP53—germ cell cancer	2.67e-05	0.000374	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AVP—germ cell cancer	2.63e-05	0.000369	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—HRAS—germ cell cancer	2.6e-05	0.000364	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AVP—germ cell cancer	2.57e-05	0.00036	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MYC—germ cell cancer	2.55e-05	0.000358	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—HRAS—germ cell cancer	2.55e-05	0.000358	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—OXT—germ cell cancer	2.49e-05	0.000349	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—OXT—germ cell cancer	2.46e-05	0.000345	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CRABP1—germ cell cancer	2.45e-05	0.000344	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.43e-05	0.000341	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—OXT—germ cell cancer	2.43e-05	0.000341	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AVP—germ cell cancer	2.39e-05	0.000335	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AVP—germ cell cancer	2.33e-05	0.000327	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF4—germ cell cancer	2.33e-05	0.000327	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CRABP1—germ cell cancer	2.31e-05	0.000324	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—OXT—germ cell cancer	2.3e-05	0.000323	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.3e-05	0.000322	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—OXT—germ cell cancer	2.27e-05	0.000318	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.26e-05	0.000317	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.26e-05	0.000317	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.19e-05	0.000307	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGFR3—germ cell cancer	2.18e-05	0.000306	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGFR3—germ cell cancer	2.18e-05	0.000306	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	2.17e-05	0.000304	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC2A3—germ cell cancer	2.17e-05	0.000304	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC2A3—germ cell cancer	2.15e-05	0.000301	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC22A3—germ cell cancer	2.13e-05	0.000299	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF4—germ cell cancer	2.12e-05	0.000298	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC22A3—germ cell cancer	2.11e-05	0.000296	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF4—germ cell cancer	2.1e-05	0.000295	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TP53—germ cell cancer	2.1e-05	0.000294	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—H2AFZ—germ cell cancer	2.08e-05	0.000292	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF4—germ cell cancer	2.08e-05	0.000291	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—OXT—germ cell cancer	2.01e-05	0.000282	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—KIT—germ cell cancer	2.01e-05	0.000281	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—HRAS—germ cell cancer	2e-05	0.000281	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—KIT—germ cell cancer	2e-05	0.00028	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF4—germ cell cancer	1.96e-05	0.000275	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	1.93e-05	0.000271	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—KITLG—germ cell cancer	1.91e-05	0.000268	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—H2AFZ—germ cell cancer	1.9e-05	0.000266	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—H2AFZ—germ cell cancer	1.88e-05	0.000263	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AVP—germ cell cancer	1.87e-05	0.000262	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—OXT—germ cell cancer	1.87e-05	0.000262	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—H2AFZ—germ cell cancer	1.85e-05	0.00026	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CRABP1—germ cell cancer	1.85e-05	0.000259	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.83e-05	0.000257	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.81e-05	0.000253	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.8e-05	0.000252	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—H2AFZ—germ cell cancer	1.75e-05	0.000246	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—KITLG—germ cell cancer	1.74e-05	0.000245	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.74e-05	0.000244	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—KITLG—germ cell cancer	1.73e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	1.73e-05	0.000242	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.72e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	1.72e-05	0.000241	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—KITLG—germ cell cancer	1.71e-05	0.000239	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AVP—germ cell cancer	1.7e-05	0.000239	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AVP—germ cell cancer	1.69e-05	0.000237	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AVP—germ cell cancer	1.67e-05	0.000234	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KITLG—germ cell cancer	1.61e-05	0.000226	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	1.6e-05	0.000224	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	1.59e-05	0.000223	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AVP—germ cell cancer	1.58e-05	0.000221	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—germ cell cancer	1.57e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AVP—germ cell cancer	1.55e-05	0.000218	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	1.53e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—HRAS—germ cell cancer	1.5e-05	0.000211	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.47e-05	0.000207	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—germ cell cancer	1.47e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—HRAS—germ cell cancer	1.47e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	1.43e-05	0.0002	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGFR3—germ cell cancer	1.42e-05	0.000199	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.42e-05	0.000198	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	1.41e-05	0.000198	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—HRAS—germ cell cancer	1.4e-05	0.000197	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.39e-05	0.000196	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AVP—germ cell cancer	1.38e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	1.31e-05	0.000184	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—KIT—germ cell cancer	1.31e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGFR3—germ cell cancer	1.3e-05	0.000182	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGFR3—germ cell cancer	1.28e-05	0.00018	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AVP—germ cell cancer	1.28e-05	0.00018	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGFR3—germ cell cancer	1.27e-05	0.000178	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGFR3—germ cell cancer	1.2e-05	0.000168	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—germ cell cancer	1.19e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—KIT—germ cell cancer	1.19e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	1.18e-05	0.000166	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—KIT—germ cell cancer	1.18e-05	0.000165	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—KIT—germ cell cancer	1.16e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—HRAS—germ cell cancer	1.14e-05	0.00016	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.14e-05	0.000159	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MYC—germ cell cancer	1.1e-05	0.000155	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KIT—germ cell cancer	1.1e-05	0.000154	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MYC—germ cell cancer	1.1e-05	0.000154	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KIT—germ cell cancer	1.08e-05	0.000152	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	1.05e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	9.75e-06	0.000137	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KIT—germ cell cancer	9.63e-06	0.000135	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—HRAS—germ cell cancer	9.56e-06	0.000134	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—germ cell cancer	9.06e-06	0.000127	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—germ cell cancer	9.04e-06	0.000127	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KIT—germ cell cancer	8.95e-06	0.000125	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—HRAS—germ cell cancer	8.71e-06	0.000122	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—HRAS—germ cell cancer	8.67e-06	0.000121	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—HRAS—germ cell cancer	8.65e-06	0.000121	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—HRAS—germ cell cancer	8.63e-06	0.000121	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—HRAS—germ cell cancer	8.52e-06	0.000119	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—HRAS—germ cell cancer	8.06e-06	0.000113	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	7.93e-06	0.000111	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MYC—germ cell cancer	7.19e-06	0.000101	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	7.04e-06	9.88e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MYC—germ cell cancer	6.55e-06	9.18e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	6.55e-06	9.18e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MYC—germ cell cancer	6.49e-06	9.1e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MYC—germ cell cancer	6.41e-06	8.98e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MYC—germ cell cancer	6.06e-06	8.5e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MYC—germ cell cancer	5.97e-06	8.36e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—germ cell cancer	5.9e-06	8.27e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HRAS—germ cell cancer	5.64e-06	7.91e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—germ cell cancer	5.38e-06	7.54e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—germ cell cancer	5.33e-06	7.47e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MYC—germ cell cancer	5.3e-06	7.43e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—germ cell cancer	5.26e-06	7.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HRAS—germ cell cancer	5.14e-06	7.21e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HRAS—germ cell cancer	5.1e-06	7.14e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HRAS—germ cell cancer	5.03e-06	7.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—germ cell cancer	4.98e-06	6.98e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MYC—germ cell cancer	4.92e-06	6.9e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—germ cell cancer	4.9e-06	6.87e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HRAS—germ cell cancer	4.76e-06	6.67e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	4.69e-06	6.57e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—germ cell cancer	4.35e-06	6.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	4.16e-06	5.83e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—germ cell cancer	4.04e-06	5.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	3.87e-06	5.42e-05	CbGpPWpGaD
